Waheed Baksh, MD
Pain Medicine · Winchester, VANPI 1033393871
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,378 of the $7,047 with a category attached, or 62.1%. 25 manufacturers reported payments, led by Medtronic at 48.1% of the total. Reporting peaked in 2022 at $2,791 and has fallen 90.9% since, to $254 in 2025.
Across 209 payments — averaging $33.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Abbott$1K
- Flowonix Medical Incorporated$696
- Biodelivery Sciences International, Inc.$274
- Collegium Pharmaceutical, Inc.$248
- Curonix LLC$217
- plus $1K from 19 others
What the payments were for
- Travel & lodging$2,07429%
- Food & beverage$4,37862%
- Entertainment$5968%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 55 | $3,391 |
| Abbott | 82 | $1,145 |
| Flowonix Medical Incorporated | 2 | $696 |
| Biodelivery Sciences International, Inc. | 17 | $274 |
| Collegium Pharmaceutical, Inc. | 14 | $248 |
| Curonix LLC | 3 | $217 |
| Boston Scientific | 6 | $154 |
| SPR Therapeutics, Inc | 2 | $146 |
| Vertos Medical, Inc. | 1 | $97 |
| Stimwave Technologies Incorporated | 1 | $93 |
| Fidia Pharma USA Inc. | 6 | $87 |
| Neuronetics, Inc. | 1 | $78 |
| Mallinckrodt Hospital Products Inc. | 3 | $63 |
| Biotronik NRO, Inc. | 1 | $52 |
| Johnson & Johnson | 2 | $45 |
| Kowa Pharmaceuticals America, Inc. | 2 | $38 |
| Daiichi Sankyo Inc. | 2 | $32 |
| Stryker | 1 | $32 |
| Hikma Pharmaceuticals USA | 2 | $28 |
| Painteq LLC | 1 | $25 |
| Nalu Medical, Inc. | 1 | $24 |
| Nevro Corp. | 1 | $23 |
| Si-bone, Inc. | 1 | $22 |
| Pfizer | 1 | $19 |
| Redhill Biopharma Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,047 in reported general payments places this provider in the 80th percentile of 150 pain medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,807 | $54,817 |
| Xtampza ErOxycodone Myristate | 82 | $41,529 |
| RelistorMethylnaltrexone Bromide | 13 | $30,454 |
| OxycontinOxycodone Hcl | 55 | $27,489 |
| BelbucaBuprenorphine Hcl | 22 | $18,051 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 565 | $11,408 |
| Fentanyl | 101 | $8,446 |
| Gabapentin | 505 | $6,277 |
| Pregabalin | 153 | $4,917 |
| Methadone Hcl | 167 | $3,206 |
| Morphine Sulfate ErMorphine Sulfate | 180 | $2,922 |
| Hydrocodone-IbuprofenHydrocodone/Ibuprofen | 12 | $2,818 |
| Tramadol Hcl | 237 | $2,152 |
| Oxycodone Hcl | 57 | $1,578 |
| Hydromorphone Hcl | 118 | $1,391 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $248 | $59,580104 claims |
| Hikma Pharmaceuticals USAMorphine Sulfate | $28 | $22917 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 150 pain medicine providers in Virginia.
Other pain medicine in Winchester
- Rehan WaheedWinchester$15K
- Chheany UngRoanoke$198K
- Daniel KendallMc Lean$100K
- Steven GershonVirginia Beach$78K
- Jared DavisFishersville$45K
- Nameer HaiderWoodbridge$36K
- Lynn KohanCharlottesville$30K
- George BaylorSalem$24K
- Jasmit BrarLansdowne$18K
- Christina ShinCharlottesville$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.